PRFree
R

roshanimrr

@roshanimrr · Author · 264 Releases

RSS Feed

Tregalizumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
March 27, 2015
Cosentyx (secukinumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
March 25, 2015
Sirukumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023-Competitive Landscape
March 25, 2015
Sarilumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
March 25, 2015
Iguratimod/T-614 (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
March 25, 2015
Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
March 24, 2015
Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
March 24, 2015
Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
March 24, 2015
Enbrel (etanercept) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023
March 24, 2015
PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis to 2023
March 20, 2015
PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023
March 20, 2015
PharmaPoint: Macular Edema and Degeneration - Japan Drug Forecast and Market Analysis to 2023
March 20, 2015
Cystinosis Global Clinical Trials Review, H1, 2015
March 19, 2015
Glomerulonephritis Global Clinical Trials Review, H1, 2015
March 19, 2015